Naturally Splendid (TSXV:NSP) announced that the directors of the Company have approved the re-pricing of 310,000 outstanding stock options from an exercise price of $0.20 to $0.285 and extending the expiry dates of those stock options to March 24, 2019. The amended stock options are held by directors, officers, consultants and employees of the Company.
The Company also announces that it has granted a total 305,000 stock options to certain employees and consultants of the Company. Each stock option is exercisable at a price of $0.295 per share, subject to certain vesting requirements and expires on March 8, 2018, in respect of 155,000 stock options, and December 1, 2018, in respect of 150,000 stock options.
Connect with Naturally Splendid (TSXV:NSP) to receive an Investor Kit.
Matica Enterprises Inc. (CSE: MMJ) (OTCQB: MMJFF) (FSE: 39N) (“Matica” or the “Company”) reports the Company has granted 6,500,000 stock options exercisable at $0.05 for five years from date of grant. These include 4,000,000 options to two officers (who are also directors) and, 2,500,000 to two consultants.
The Company welcomes adult-use customers at its eight dispensaries across the state and will create 120 new jobs in surrounding communities
– Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading U.S. provider of consumer products in cannabis, today announced it will begin serving adult-use consumers across its eight dispensaries in Arizona .
Harvest Health & Recreation Inc. (“Harvest”) (CSE: HARV, OTCQX: HRVSF), a vertically integrated cannabis company and multi-state operator in the U.S., today announced the launch of recreational cannabis sales in Arizona .
Jason Mitchell Co-Founder, Director and Chief Executive Officer, HempFusion Wellness Inc. (“HempFusion” or the “Company”) (TSX: CBD.U), and his team joined David Chelich Sector Head, Global Energy and Diversified Industries, TMX Group, to celebrate the Company’s new listing on Toronto Stock Exchange and open the market.
Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce that it is one of the seventeen companies in the U.S. and Canada that will be included in the First Psychedelics Exchange Traded Fund, which is managed by Horizons ETF Management.
The Horizons Psychedelic Stock Index ETF index is expected to start trading on Tuesday, January 26, under the ticker PSYK on the NEO exchange.